(xi) Exercise price, grant date and vesting schedule Date of grant Exercise price Closing price immediately preceding the date of grant Vesting period Exercise period Held at 1 January 2022 Granted during the period Exercised during the period Cancelled during the period Lapsed during the period Held at 30 June 2022 Directors 8 June 2022 HK$22.78 HK$22.50 vest in three equal tranches on each of 8 June 2022, 8 June 2023 and 8 June 2024 8 June 2022 to 7 June 2032 Mr Jinchu Shen - 192,000 - - - 192,000 Mr Stuart Gibson - 192,000 - - - 192,000 Subtotal - 384,000 - - - 384,000 Management (other than Directors) and employees 28 December 2020 HK$27.30 HK$27.10 vest in three equal tranches on each of 28 December 2021, 28 December 2022 and 28 December 2023 28 December 2021 to 27 December 2030 6,650,000 - - - - 6,650,000 23 August 2021 HK$24.50 HK$23.80 vest in three equal tranches on each of 23 August 2021, 23 August 2022 and 23 August 2023 23 August 2021 to 22 August 2031 11,485,600 - - - - 11,485,600 Subtotal 18,135,600 - - - - 18,135,600 Grand total 18,135,600 384,000 - - - 18,519,600 During the six months ended 30 June 2022, a total of 384,000 Share Options were granted to directors under the Post-IPO Share Option scheme with a fair value on the date of grant of approximately HK$8.88 (approximately US$1.13) per Share Option. Details of the fair value are set out in Note 25 of the Unaudited Condensed Consolidated Financial Information. Save as disclosed above, no other share option schemes were entered into by the Company. E S R G R O U P L I M I T E D I N T E R I M R E P O R T 2 0 2 2 29
RkJQdWJsaXNoZXIy ODIwNTc=